Pyxis Oncology Inc (PYXS)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Lara S. Sullivan
Employees:
60
800 BOYLSTON STREET, SUITE 1555, BOSTON, MA 02199
(617) 351-2575

Pyxis Oncology, Inc. engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors.

Data derived from most recent annual or quarterly report
Market Cap 49.917 Million Shares Outstanding32.84 Million Avg 30-day Volume 123.77 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.93
Price to Revenue0.0 Debt to Equity0.0 EBITDA-101.669 Million
Price to Book Value0.3398 Operating Margin0.0 Enterprise Value-135.864 Million
Current Ratio10.621 EPS Growth0 Quick Ratio10.397
1 Yr BETA 0.7389 52-week High/Low 13.29 / 1.34 Profit Margin0.0
Operating Cash Flow Growth-219.5449 Altman Z-Score-0.5314 Free Cash Flow to Firm 0
View SEC Filings from PYXS instead.

View recent insider trading info

Funds Holding PYXS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PYXS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PFIZER INC

PFIZER VENTURES (US) LLC

  • 10% Owner
5,221,176 2022-10-06 1

HUMPHREY RACHEL

0 2022-08-11 2

WADHANE JITENDRA SVP, CHIEF ACCOUNTING OFFICER

  • Officer
43,648 2022-08-03 1

BARCLAYS PLC

  • 10% Owner
0 2022-04-26 2

CHIN MARK

  • FORMER DIRECTOR
0 2022-04-21 2

SULLIVAN LARA CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,356,636 2022-04-14 2

YANCHIK CONNEALY PAMELA CHIEF FINANCIAL OFFICER

  • Officer
341,017 2022-04-14 3

FEINGOLD JAY CHIEF MEDICAL OFFICER

  • Officer
466,611 2022-04-14 2

FLAVIN JOHN L

238,441 2022-03-31 1

LEWIS-HALL FREDA C

66,831 2022-03-31 1

CLINE DARREN S

76,831 2022-03-31 2

CIVIK THOMAS

82,531 2022-03-31 1

BAYER WORLD INVESTMENTS B.V.

BAYER AKTIENGESELLSCHAFT

  • FORMER 10% OWNERFORMER 10% OWNER
2,742,338 2021-10-13 0

CORMORANT ASSET MANAGEMENT, LP

CHEN BIHUA

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

CORMORANT PRIVATE HEALTHCARE FUND III LP

  • Director
  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
1,787,708 2021-10-13 0

SHAH RITU CHIEF OPERATING OFFICER

0 2021-10-07 0

HERBST RONALD CHIEF SCIENTIFIC OFFICER

90,422 2021-10-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PYXIS ONCOLOGY INC PYXS 2022-11-25 22:15:03 UTC -2.4173 6.2373 70000
PYXIS ONCOLOGY INC PYXS 2022-11-25 21:45:04 UTC -2.4086 6.2286 70000
PYXIS ONCOLOGY INC PYXS 2022-11-25 21:15:03 UTC -2.4086 6.2286 70000
PYXIS ONCOLOGY INC PYXS 2022-11-25 20:45:03 UTC -2.4259 6.2459 70000
PYXIS ONCOLOGY INC PYXS 2022-11-25 20:15:03 UTC -2.4259 6.2459 70000
PYXIS ONCOLOGY INC PYXS 2022-11-25 19:45:04 UTC -2.4259 6.2459 70000
PYXIS ONCOLOGY INC PYXS 2022-11-25 19:15:03 UTC -2.4259 6.2459 70000
PYXIS ONCOLOGY INC PYXS 2022-11-25 18:45:03 UTC -2.4063 6.2263 70000
PYXIS ONCOLOGY INC PYXS 2022-11-25 18:15:03 UTC -2.4063 6.2263 75000
PYXIS ONCOLOGY INC PYXS 2022-11-25 17:45:04 UTC -2.4063 6.2263 80000
PYXIS ONCOLOGY INC PYXS 2022-11-25 17:15:03 UTC -2.4063 6.2263 85000
PYXIS ONCOLOGY INC PYXS 2022-11-25 16:45:04 UTC -2.4359 6.2559 85000
PYXIS ONCOLOGY INC PYXS 2022-11-25 16:15:03 UTC -2.4359 6.2559 90000
PYXIS ONCOLOGY INC PYXS 2022-11-25 15:45:03 UTC -2.4359 6.2559 90000
PYXIS ONCOLOGY INC PYXS 2022-11-25 15:15:03 UTC -2.4359 6.2559 95000
PYXIS ONCOLOGY INC PYXS 2022-11-25 14:45:04 UTC -2.4359 6.2559 95000
PYXIS ONCOLOGY INC PYXS 2022-11-25 14:15:04 UTC -2.4359 6.2559 95000
PYXIS ONCOLOGY INC PYXS 2022-11-25 13:45:03 UTC -2.4359 6.2559 95000
PYXIS ONCOLOGY INC PYXS 2022-11-25 13:15:03 UTC -2.4359 6.2559 95000
PYXIS ONCOLOGY INC PYXS 2022-11-25 12:45:03 UTC -2.4359 6.2559 95000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments